Table 1 Patient characteristics at renal biopsy

Age, years

45

(±16)

–

Sex, female, n (%)

94

(79)

–

Observation period, days

2958

(±2584)

–

SLEDAI-2 K score

16

(±6)

53.8

ISN/RPS classification

Class III, n (%)

20

(17)

–

Class III + V, n (%)

2

(10)

–

Class IV, n (%)

84

(71)

–

Class IV + V, n (%)

7

(8)

0.8

Class V, n (%)

15

(13)

–

Max dose of PSL, mg/day

37

(±15)

5.0

Immunosuppressive therapy for remission induction

4.2

PSL alone, n (%)

46

(39)

Cyclophosphamide, n (%)

31

(26)

–

Tacrolimus or cyclosporine, n (%)

22

(19)

–

Mycophenolate mofetil, n (%)

13

(11)

–

Others, n (%)

2

(2)

–

Serum creatinine, mg/dl

0.87

(±0.51)

–

eGFR, ml/min/m²

77.3

(±31.0)

–

Urinary protein, g/gCr

3.00

(±2.78)

–

Hematuria (scale > 2+), n (%)

52

(44)

2.5

Active urinary sediment, n (%)

77

(65)

4.2